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Aims: Non-dipper hypertension is associated with increased cardiovascular morbidity
and mortality. Several studies have suggested that the interval from the peak to the end
of the electrocardiographic T wave (Tp-e) may correspond to the transmural disper-
sion of repolarization and that increased Tp-e interval and Tp-e/QT ratio are associated
with malignant ventricular arrhythmias. The aim of this study was to evaluate
ventricular repolarization by using Tp-e interval and Tp-e/QT ratio in patients with
nondipper hypertension.
Materials-Method: This study included 80 hypertensive patients. Hypertensive
patients were divided into two groups: 50 dipper patients (29 male, mean age 51.58
years) and 30 non-dipper patients (17 male, mean age 50.65.4 years). Tp-e interval
and Tp-e/QT ratio were measured from the 12-lead electrocardiogram. These
parameters were compared between groups.
Results: No statistically signiﬁcant difference was found between two groups in terms
of basic characteristics. In electrocardiographic parameters analysis, QT dispersion
(QTd) and corrected QTd were signiﬁcantly increased in nondipper patients compared
to the dippers (39.411.5 vs 27.37.5 milliseconds and 37.59.5 vs 29.26.5
milliseconds, P¼0.001 and P¼0.01, respectively). Tp-e interval and Tp-e/QT ratio
were also signiﬁcantly higher in nondipper patients (97.511.2 vs 84.28.3 milli-
seconds and 0.230.02 vs 0.170.02, all P value <0.001).
Conclusion: Our study revealed that QTd, Tp-e interval and Tp-e/QT ratio are pro-






Age (years) 51.5  8 50.6  5.4 0.2
Sex (n,%) males 29 (58%) 17 (56.6%) 0.62
Creatinine (mg/dl) 0.92 0.12 1.1  0.18 0.24
LV ejection fraction (%) 63.6 14.4 61.4 8.5 0.24
LV mass index (g/m2) 111.6  21.2 147 25.7 0.001
QT dispersion (QTd) (ms) 27.37.5 39.411.5 0.001
corrected QT dispersion (cQTd) 29.26.5 37.59.5 0.01
Tp-e interval 84.28.3 97.511.2 <0.001
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Objectives: The aim of this study was to compare the accuracies of different
cardiovascular disease (CVD) risk scoring systems in predicting cardiovascular (CV)
events in a group of Turkish patients with uncomplicated hypertension.
Methods: The study group consisted of 100 patients (37 male, 63 female, aged 5412
years) admitted between 2000-2001. The 10-years risks were calculated using Fra-
mingham, SCORE, PROCAM and TEKHARF risk scores. CV endpoints were
deﬁned as death due to CVD and coronary heart disease (CHD). Follow-up was
achieved using phone calls and/or clinical visits.
Results: Percentage of high risk group patients were 20%, 25%, 33% and 49%
according to PROCAM, TEKHARF, Framingham and SCORE risk classiﬁcations,
respectively. Concordance between scales to classify patients into the same riskJACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/ORAgroups was low and differences were signiﬁcant for all the comparisons (p<0,001 for
all). During a mean follow-up of 10, 60, 9 years, 42 CVD events were determined, 9
of which were death due to CVD. In ROC analysis, SCORE and PROCAM models
had higher area under curves for death due to CVD (AUC 0.73 vs. 0.72) compared to
Framingham and TEKHARF risk scores (AUC 0.58 vs. 0.69), but the differences were
not statistically signiﬁcant. For CHD, the only model that estimated events success-
fully was SCORE (AUC 0,71 95% CI 0,61-0,80; p<0,001) with a predictive cut-off
value of >3%.
Conclusion: This study indicates that SCORE is probably the most suitable CVD risk
estimation method in patients with hypertension. However, due to lack of adequate
studies regarding this issue, we need more comprehensive, prospective studies for
determination of the most suitable risk evaluation system for our population.
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Objective: The lack of a normal nocturnal fall in blood pressure (non-dipper) in
hypertension is associated with more prominent target organ damage and increased
risk for subsequent cardiovascular and renal disease. Increasing evidence supports the
view that inﬂammation may participate in the development and deﬁne the outcome of
hypertension. The aim of the study is the evaluation of Galactin-3, a b-galactoside-
binding lectin that plays an important role in inﬂammatory diseases, in non-dipper
hypertension.
Methods: 88 hypertensive patients without diabetes and 39 healthy subjects as control
group had been enrolled in this study. Plasma Galectin-3 levels had been measured
with enzyme-linked immuno sorbent assay (ELISA). 24-hour ambulatory blood
pressure monitoring allowed allocation of study population into 2 groups: 42 patients
with dipper hypertension and 46 non-dipper hypertension.
Results: There was no difference between groups regarding age, sex or body mass
index. Galactin-3 levels were signiﬁcantly higher in non-dipper hypertensive patients
compared to control subjects (1,190,86 ng/ml versus 0,780,09 ng/ml; p¼0,01)
while for dipping hypertensive patients the difference with control subjects was not
signiﬁcant (1,090,59 ng/ml versus 0,78,09 ng/ml; p¼0,07). Non-dipper hyper-
tension patients had also higher levels of galectin-3 compared to dipper patients but
again the difference was not signiﬁcant (1,190,86 ng/ml versus 1,090,59 ng/ml;
p¼0,7).
Conclusion: The high levels of inﬂammatory molecule galectin-3 in non-dipper
hypertension may be one of the mechanisms to explain the increased cardiovascular
risk reported by previous studies in this group of patients. Large scale studies are
necessary to test this hypothesis.
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Introduction: Prehypertension is deﬁned as a systolic blood pressure (SBP) of 120-
139 mmhg or/ and a diastolic blood pressure (DBP) of 80-89 mmhg. Prehypertensive
patients have higher risk of developing hypertension in their life time than those with
blood pressure <120/80 mmhg. Impaired left ventricular systolic function is associ-
ated with poor outcomes in patients with hypertension. In our study, we aimed to show
the impact of prehypertension on left ventricular mechanics in prehypertensive
patients with preserved ejection fraction using speckle tracking echocardiography
(STE).
Methods: Between December 2010 and February 2011, 136 patients were enrolled in
this study. As measured by outpatient, the patients who had SBP ranging from
120-139 mmhg or/and DBP ranging from 80-89 mmhg constituted the pre-
hypertensive population (group 1) and the patients who had SBP lower than
120 mmhg and DBP lower than 80 mmhg constituted the control population (group 2).
The prehypertensive patient group was divided into 2 subgroups: SBP between 130
and 139 mm Hg and/or DBP between 85 and 89 mmHg were deﬁned ‘high normal’,
whereas SBP between 120 and 129 mm Hg an/or DBP between 80 and 84 mmHg
were deﬁned ‘normal’. Patients who had blood pressure 140-90 mmhg, diabetes
mellitus, thyroid dysfunction, anemia, chronic obstructive pulmonary disease, renal
disorder, structural heart disease and moderate or severe valvular heart disease were
excluded from the study. In STE examination, left ventricular strain, peak longitudinal
strain were calculated from apical 4 chamber, 2 chamber and long axis images and
global strain was calculated from the average of apical 4 chamber, 3 chamber and 2
chamber images.
Results: There were 66 patients (mean age 49.2 6, 37 male) in group 1 and 70
patients (mean age 47.6 6, 36 male) in group 2. There were no differences betweenLS C13
